DOWNLOAD
1 min read • Healthcare & Life Sciences, Digital Shift
Digital Pharma - Responding to Challenges and Opportunities from Outside
Innovation has always been one of the foundations for success in the pharmaceutical industry. While the sector has been very good at developing innovation from scratch or incremental innovation of existing products, it now faces an ultimately different challenge ╨ dealing with disruptive innovation that is driven by inventions outside the healthcare sector.
1 min read • Healthcare & Life Sciences, Digital Shift
Digital Pharma - Responding to Challenges and Opportunities from Outside
Innovation has always been one of the foundations for success in the pharmaceutical industry. While the sector has been very good at developing innovation from scratch or incremental innovation of existing products, it now faces an ultimately different challenge ╨ dealing with disruptive innovation that is driven by inventions outside the healthcare sector.
RELATED INFORMATION
Opportunities and challenges for Global Deepwater Players
The pace of deepwater drilling has increased by 40 % over the last three years. While technology is a key enabler for deepwater development, players still face many critical challenges and decisions…
Nine out of 10 firms dissatisfied with their breakthrough innovation performance, says Arthur D. Little Study
Just one in 10 firms is confident that its business has the right approach to breakthrough innovation, according to a new study from Arthur D. Little (ADL). In Breakthrough Innovation, ADL found that…
Arthur D. Little study reveals the Future of Medtech requires a well-designed Innovation Management System
Healthcare providers are under pressure to deliver improved medical outcomes while consuming fewer resources. Arthur D. Little’s (ADL) recent global Innovation Excellence study demonstrates that a…